The Black-participant share in landmark drug trials: a primer on what 'trial diversity gap' really means and how to read a race-stratified subgroup analysis
By the Black Health editorial team. Primary author: Devon Osei, PhD, MPH.A Phase 3 hepatitis D trial published in the New England Journal of Medicine in 2023 enrolled 150 patients across Germany, Sweden, Italy, and …